JPS56150067A - Antitumor composition - Google Patents
Antitumor compositionInfo
- Publication number
- JPS56150067A JPS56150067A JP804481A JP804481A JPS56150067A JP S56150067 A JPS56150067 A JP S56150067A JP 804481 A JP804481 A JP 804481A JP 804481 A JP804481 A JP 804481A JP S56150067 A JPS56150067 A JP S56150067A
- Authority
- JP
- Japan
- Prior art keywords
- antitumor composition
- antitumor
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11480980A | 1980-01-24 | 1980-01-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56150067A true JPS56150067A (en) | 1981-11-20 |
JPH032862B2 JPH032862B2 (ja) | 1991-01-17 |
Family
ID=22357561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP804481A Granted JPS56150067A (en) | 1980-01-24 | 1981-01-23 | Antitumor composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS56150067A (ja) |
BE (1) | BE887220A (ja) |
ZA (1) | ZA81420B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56142265A (en) * | 1980-03-11 | 1981-11-06 | Warner Lambert Co | Salts of 4'-(9-acridinylamino)methanesulfone- m-anisidide |
WO1994009650A1 (en) * | 1992-10-27 | 1994-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Bifidobacterium growth promoter |
-
1981
- 1981-01-21 ZA ZA00810420A patent/ZA81420B/xx unknown
- 1981-01-23 BE BE0/203590A patent/BE887220A/fr not_active IP Right Cessation
- 1981-01-23 JP JP804481A patent/JPS56150067A/ja active Granted
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56142265A (en) * | 1980-03-11 | 1981-11-06 | Warner Lambert Co | Salts of 4'-(9-acridinylamino)methanesulfone- m-anisidide |
JPH0343269B2 (ja) * | 1980-03-11 | 1991-07-01 | Warner Lambert Co | |
WO1994009650A1 (en) * | 1992-10-27 | 1994-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Bifidobacterium growth promoter |
Also Published As
Publication number | Publication date |
---|---|
JPH032862B2 (ja) | 1991-01-17 |
ZA81420B (en) | 1982-02-24 |
BE887220A (fr) | 1981-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5731700A (en) | Pharmaceutic composition | |
JPS56152451A (en) | Novel composition | |
DE3164692D1 (en) | Ultraviolet-transmissible composition | |
JPS5740518A (en) | Self-oxidizable composition | |
GB2142378B (en) | Combination | |
JPS579716A (en) | Antitumor composition | |
GB8411035D0 (en) | Formaldehyde-binding compositions | |
JPS5722142A (en) | Glass composition | |
JPS573839A (en) | Composition | |
JPS56160705A (en) | Metallized composition | |
JPS56160704A (en) | Metallized composition | |
EP0055593A3 (en) | Compositions comprising e-prostaglandins | |
DE3171421D1 (en) | Anaerobically-curing compositions | |
GB2079153B (en) | Acetal-acid compositions | |
GB2064534B (en) | Antitumor compositions | |
JPS56150067A (en) | Antitumor composition | |
GB2067403B (en) | Bezodiazepine compositions | |
JPS5759941A (en) | Composition | |
JPS5788060A (en) | Complex type composition | |
JPS5771850A (en) | Composition | |
GB2068729B (en) | Antitumour compositions | |
EP0046036A3 (en) | Compositions | |
JPS56128504A (en) | Conductive composition | |
DE3171419D1 (en) | Anaerobically-curing compositions | |
JPS57104290A (en) | Metallized composition |